Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Outlook Therapeutics (OTLK) Long-Term Debt Issuances (2016 - 2017)

Historic Long-Term Debt Issuances for Outlook Therapeutics (OTLK) over the last 3 years, with Q2 2017 value amounting to $5.0 million.

  • Outlook Therapeutics' Long-Term Debt Issuances rose 306758466.26% to $5.0 million in Q2 2017 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year change of. This contributed to the annual value of $33.1 million for FY2025, which is N/A changed from last year.
  • As of Q2 2017, Outlook Therapeutics' Long-Term Debt Issuances stood at $5.0 million, which was up 306758466.26% from $1.6 million recorded in Q1 2017.
  • Outlook Therapeutics' Long-Term Debt Issuances' 5-year high stood at $8.4 million during Q4 2016, with a 5-year trough of -$163.0 in Q2 2016.
  • Over the past 3 years, Outlook Therapeutics' median Long-Term Debt Issuances value was $1.1 million (recorded in 2016), while the average stood at $2.3 million.
  • In the last 5 years, Outlook Therapeutics' Long-Term Debt Issuances tumbled by 10000.65% in 2016 and then soared by 306758466.26% in 2017.
  • Over the past 3 years, Outlook Therapeutics' Long-Term Debt Issuances (Quarter) stood at $187388.0 in 2015, then surged by 4356.0% to $8.4 million in 2016, then tumbled by 40.12% to $5.0 million in 2017.
  • Its last three reported values are $5.0 million in Q2 2017, $1.6 million for Q1 2017, and $8.4 million during Q4 2016.